Category Archives: Hypertension

11/01/2020 | 01:35pm EST PUBLISHED30 October 2020 30 October 2020 07:00 GMT Agreement supports strategy of focusing on newer medicines in main therapy areas AstraZeneca has agreed to sell the commercial rights to Atacand (candesartan cilexetil) and Atacand Plus (a fixed-dose combination of candesartan cilexetil and hydrochlorothiazide) in around 70 countries globally to Cheplapharm Arzneimittel GmbH (Cheplapharm). Atacand is a prescription medicine approved for the treatment of heart failure (HF) and hypertension. Atacand Plus is approved for the treatment of hypertension. Continue reading →

Comprehensive quantitative and qualitative research on Hypertension Drugs Market. Continue reading →

The family of a fisheries observer who died onboard a Taiwanese ship earlier this year are demanding answers from authorities after the ship and its crew were released, and the cause of death changed from blunt force trauma to complications from hypertension. Continue reading →

Idiopathic Intracranial Hypertension Treatment Market Scope of the Report: The worldwide market for Idiopathic Intracranial Hypertension Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2025, from xx million US$ in 2018, according to a new study. This report focuses on the Idiopathic Intracranial Hypertension Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa Continue reading →

(Photo courtesy: AFP Relaxnews/ stockvisual/ Istock.com) A study found that loneliness and social isolation increased more risk of high blood pressure and hypertension in women. Continue reading →

Pulmonary Arterial Hypertension (PAH) Market Overview 2020 2025 This has brought along several changes in This report also covers the impact of COVID-19 on the global market. The risingtechnology in Pulmonary Arterial Hypertension (PAH) Marketis also depicted in thisresearchreport Continue reading →

This article was originally published here Medicine (Baltimore). 2020 Oct 23;99(43):e22952. doi: 10.1097/MD.0000000000022952. Continue reading →

CHANDIGARH:To further spread awareness among all the diabetic & hypertension patients of Punjab to adopt preventive measures and scheduled their diet and exercise routine, the Health & Family Welfare Minister Mr. Balbir Singh Sidhu wrote letters to all such patients Continue reading →

The killer Covid-19 virus makes victims to most of the diabetics and hypertensive patients in Telangana compared to other states in India. Continue reading →

Up to 40% of patients with cancer who are treated with bevacizumab develop severe hypertension and renal toxicity. But now, a simple genetic test performed before treatment could identify patients at highest risk for this potentially life-threatening complication, investigators said. A study of genetic variants in more than 1000 patients treated with bevacizumab in clinical trials found that those who developed kidney toxicities were more than twice as likely to have a single-nucleotide polymorphism (SNP) that has been associated with kidney disease than patients who did not develop kidney toxicity Continue reading →